YS 035

Drug Profile

YS 035

Alternative Names: MR 827

Latest Information Update: 21 Oct 1997

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Medea Research; SIR International
  • Class Anti-inflammatories; Cardiotonics; Class III antiarrhythmics
  • Mechanism of Action Calcium channel antagonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.


Highest Development Phases

  • Discontinued Arrhythmias

Most Recent Events

  • 21 Oct 1997 Discontinued - Preclinical for Arrhythmias (Unknown route)
  • 04 Apr 1997 No-Development-Reported for Arrhythmias (Unknown route)
  • 09 Dec 1994 Preclinical development for Arrhythmias (Unknown route)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top